Bruce A. Lefker

Person

Gales Ferry, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Dibenzyl amine compounds and derivatives
- Patent number 8,383,660
- Issue date Feb 26, 2013
- Pfizer Inc.
- George Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dibenzyl amine compounds and derivatives
- Patent number 7,919,506
- Issue date Apr 5, 2011
- Pfizer Inc.
- George Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Androgen modulators
- Patent number 7,799,823
- Issue date Sep 21, 2010
- Warner-Lambert Company LLC
- Stephen Douglas Barrett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Androgen modulators
- Patent number 7,674,819
- Issue date Mar 9, 2010
- Warner-Lambert Company LLC
- Stephen Douglas Barrett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Androgen modulators
- Patent number 7,670,613
- Issue date Mar 2, 2010
- Pfizer Inc.
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Androgen receptor modulators
- Patent number 7,576,128
- Issue date Aug 18, 2009
- Pfizer Inc.
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Androgen modulators
- Patent number 7,507,860
- Issue date Mar 24, 2009
- Pfizer Inc.
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopentapyridine and tetrahydroquinoline derivatives
- Patent number 7,507,732
- Issue date Mar 24, 2009
- Pfizer Inc.
- Bruce A. Lefker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Androgen modulators
- Patent number 7,473,711
- Issue date Jan 6, 2009
- Pfizer Inc.
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prostaglandin agonists
- Patent number 7,442,702
- Issue date Oct 28, 2008
- Pfizer Inc.
- Kimberly O. Cameron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treatment with selective EP4 receptor agonists
- Patent number 7,414,071
- Issue date Aug 19, 2008
- Pfizer Inc.
- Kimberly O. Cameron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EP4 receptor selective agonist in the treatment of osteoporosis
- Patent number 7,192,979
- Issue date Mar 20, 2007
- Pfizer Inc.
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prevention of loss and restoration of bone mass by certain prostagl...
- Patent number 6,998,423
- Issue date Feb 14, 2006
- Pfizer Inc.
- Kimberly O. Cameron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dipeptide derivatives
- Patent number 6,953,791
- Issue date Oct 11, 2005
- Pfizer, Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dipeptide derivatives
- Patent number 6,951,850
- Issue date Oct 4, 2005
- Pfizer, Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dipeptide derivatives
- Patent number 6,924,280
- Issue date Aug 2, 2005
- Pfizer Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of insulin resistance
- Patent number 6,867,202
- Issue date Mar 15, 2005
- Pfizer Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amin...
- Patent number 6,852,863
- Issue date Feb 8, 2005
- Pfizer Inc.
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EP4 receptor selective agonists in the treatment of osteoporosis
- Patent number 6,747,054
- Issue date Jun 8, 2004
- Pfizer Inc.
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dipeptide derivatives as growth hormone secretagogues
- Patent number RE38524
- Issue date Jun 1, 2004
- Pfizer Inc.
- Philip Albert Carpino
- 514 - Drug, bio-affecting and body treating compositions
Information Patent Grant
EP4 receptor selective agonists in the treatment of osteoporosis
- Patent number 6,737,437
- Issue date May 18, 2004
- Pfizer Inc.
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prevention of loss and restoration of bone mass by certain prostagl...
- Patent number 6,649,657
- Issue date Nov 18, 2003
- Pfizer Inc.
- Kimberly O. Cameron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EP4 receptor selective agonists in the treatment of osteoporosis
- Patent number 6,642,266
- Issue date Nov 4, 2003
- Pfizer Inc.
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of insulin resistance with growth hormone secretagogues
- Patent number 6,630,487
- Issue date Oct 7, 2003
- Pfizer Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
- Patent number 6,608,203
- Issue date Aug 19, 2003
- Pfizer Inc.
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tartrate salt of a substituted dipeptide as growth hormone secretag...
- Patent number 6,596,867
- Issue date Jul 22, 2003
- Pfizer Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EP4 receptor selective agonists in the treatment of osteoporosis
- Patent number 6,552,067
- Issue date Apr 22, 2003
- Pfizer Inc.
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dipeptide derivatives
- Patent number 6,525,047
- Issue date Feb 25, 2003
- Pfizer Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prostaglandin agonists and their use to treat bone disorders
- Patent number 6,498,172
- Issue date Dec 24, 2002
- Pfizer Inc.
- Kimberly O. Cameron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prevention of loss and restoration of bone mass by certain prostagl...
- Patent number 6,492,412
- Issue date Dec 10, 2002
- Pfizer, Inc.
- Kimberly O. Cameron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NOVEL PYRIDINE PYRAZINONES AS BET-FAMILY BROMODOMAIN INHIBITORS
- Publication number 20160368919
- Publication date Dec 22, 2016
- Pfizer Inc.
- Agustin Casimiro-Garcia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-OXA-7-AZABICYCLO[3.3.1]NONANES
- Publication number 20120095028
- Publication date Apr 19, 2012
- Pfizer Inc.
- Michael Paul DeNinno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GPR 119 MODULATORS
- Publication number 20120052130
- Publication date Mar 1, 2012
- Pfizer Inc.
- Etzer Darout
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidone Compounds As GSK-3 Inhibitors
- Publication number 20100292205
- Publication date Nov 18, 2010
- Pfizer Inc.
- Bruce A. Lefker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GPR 119 MODULATORS
- Publication number 20100285145
- Publication date Nov 11, 2010
- Pfizer Inc.
- Etzer Darout
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANDROGEN MODULATORS
- Publication number 20100048517
- Publication date Feb 25, 2010
- Pfizer Inc.
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIBENZYL AMINE COMPOUNDS AND DERIVATIVES
- Publication number 20090239865
- Publication date Sep 24, 2009
- George Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANDROGEN MODULATORS
- Publication number 20090192202
- Publication date Jul 30, 2009
- Pfizer Inc.
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANDROGEN MODULATORS
- Publication number 20090170886
- Publication date Jul 2, 2009
- Pfizer Inc.
- Mark Laurence Boys
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANDROGEN MODULATORS
- Publication number 20090105349
- Publication date Apr 23, 2009
- WARNER-LAMBERT COMPANY LLC
- Nicole Chantel Barvian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Androgen Modulators
- Publication number 20080064745
- Publication date Mar 13, 2008
- WARNER-LAMBERT COMPANY LLC
- Bruce Allen Lefker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzonitrile Derivatives to Treat Musculoskeletal Frailty
- Publication number 20080045504
- Publication date Feb 21, 2008
- PFIZER PRODUCTS INC.
- Thomas G. Gant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Dibenzyl Amine Compounds and Derivatives
- Publication number 20070213371
- Publication date Sep 13, 2007
- Pfizer Inc.
- George Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Dibenzyl Amine Compounds and Derivatives
- Publication number 20070213314
- Publication date Sep 13, 2007
- Pfizer Inc.
- George Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Androgen modulators
- Publication number 20070197641
- Publication date Aug 23, 2007
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Androgen modulators
- Publication number 20070197642
- Publication date Aug 23, 2007
- WARNER-LAMBERT COMPANY LLC
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANDROGEN MODULATORS
- Publication number 20070072936
- Publication date Mar 29, 2007
- Warner-Lambert Company LLC
- Stephen Douglas Barrett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Androgen modulators
- Publication number 20060252796
- Publication date Nov 9, 2006
- WARNER-LAMBERT COMPANY LLC
- Stephen Douglas Barrett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopentapyridine and tetrahydroquinoline derivatives
- Publication number 20060247254
- Publication date Nov 2, 2006
- Pfizer Inc.
- Bruce A. Lefker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Androgen modulators
- Publication number 20060009427
- Publication date Jan 12, 2006
- WARNER-LAMBERT COMPANY LLC
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Androgen receptor modulators
- Publication number 20050182132
- Publication date Aug 18, 2005
- Lain-Yen Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EP4 receptor selective agonists in the treatment of osteoporosis
- Publication number 20040259921
- Publication date Dec 23, 2004
- Pfizer Inc.
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
- Publication number 20040192685
- Publication date Sep 30, 2004
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Prevention of loss and restoration of bone mass by certain prostagl...
- Publication number 20040176461
- Publication date Sep 9, 2004
- Pfizer Inc.
- Kimberly O. Cameron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dipeptide derivatives
- Publication number 20040009984
- Publication date Jan 15, 2004
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dipeptide derivatives
- Publication number 20040006063
- Publication date Jan 8, 2004
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
- Publication number 20030220494
- Publication date Nov 27, 2003
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Dipeptide derivatives
- Publication number 20030216399
- Publication date Nov 20, 2003
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amin...
- Publication number 20030216445
- Publication date Nov 20, 2003
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of treatment with selective EP4 receptor agonists
- Publication number 20030207925
- Publication date Nov 6, 2003
- Kimberly O. Cameron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Bruce A. Lefker

Person

Patents Grantslast 30 patents

Dibenzyl amine compounds and derivatives

Dibenzyl amine compounds and derivatives

Androgen modulators

Androgen modulators

Androgen modulators

Androgen receptor modulators

Androgen modulators

Cyclopentapyridine and tetrahydroquinoline derivatives

Androgen modulators

Prostaglandin agonists

Methods of treatment with selective EP4 receptor agonists

EP4 receptor selective agonist in the treatment of osteoporosis

Prevention of loss and restoration of bone mass by certain prostagl...

Dipeptide derivatives

Dipeptide derivatives

Dipeptide derivatives

Treatment of insulin resistance

Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amin...

EP4 receptor selective agonists in the treatment of osteoporosis

Dipeptide derivatives as growth hormone secretagogues

EP4 receptor selective agonists in the treatment of osteoporosis

Prevention of loss and restoration of bone mass by certain prostagl...

EP4 receptor selective agonists in the treatment of osteoporosis

Treatment of insulin resistance with growth hormone secretagogues

Tetrahydroisoquinoline compounds as estrogen agonists/antagonists

Tartrate salt of a substituted dipeptide as growth hormone secretag...

EP4 receptor selective agonists in the treatment of osteoporosis

Dipeptide derivatives

Prostaglandin agonists and their use to treat bone disorders

Prevention of loss and restoration of bone mass by certain prostagl...

Patents Applicationslast 30 patents

NOVEL PYRIDINE PYRAZINONES AS BET-FAMILY BROMODOMAIN INHIBITORS

3-OXA-7-AZABICYCLO[3.3.1]NONANES

GPR 119 MODULATORS

Pyrimidone Compounds As GSK-3 Inhibitors

GPR 119 MODULATORS

ANDROGEN MODULATORS

DIBENZYL AMINE COMPOUNDS AND DERIVATIVES

ANDROGEN MODULATORS

ANDROGEN MODULATORS

ANDROGEN MODULATORS

Androgen Modulators

Benzonitrile Derivatives to Treat Musculoskeletal Frailty

Dibenzyl Amine Compounds and Derivatives

Dibenzyl Amine Compounds and Derivatives

Androgen modulators

Androgen modulators

ANDROGEN MODULATORS

Androgen modulators

Cyclopentapyridine and tetrahydroquinoline derivatives

Androgen modulators

Androgen receptor modulators

EP4 receptor selective agonists in the treatment of osteoporosis

Tetrahydroisoquinoline compounds as estrogen agonists/antagonists

Prevention of loss and restoration of bone mass by certain prostagl...

Dipeptide derivatives

Dipeptide derivatives

Tetrahydroisoquinoline compounds as estrogen agonists/antagonists

Dipeptide derivatives

Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amin...

Methods of treatment with selective EP4 receptor agonists